• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Patent holdings for IPC class A61K 47/60

Total number of patents in this class: 3321

10-year publication summary

72
142
248
391
471
459
486
465
413
122
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Nektar Therapeutics
503
93
Hanmi Pharm. Co., Ltd.
546
71
The Regents of the University of California
18943
53
Bristol-myers Squibb Company
5080
45
Ascendis Pharma A/S
173
45
Massachusetts Institute of Technology
9795
37
The Johns Hopkins University
5377
37
Board of Regents, The University of Texas System
5370
35
Synthorx, Inc.
69
30
Quiapeg Pharmaceuticals AB
46
27
Ascendis Pharma Growth Disorders A/S
36
27
Amgen Inc.
3779
23
Janssen Pharmaceutica N.V.
3839
22
The Board of Trustees of the Leland Stanford Junior University
6054
20
Ascendis Pharma Bone Diseases A/S
39
20
Northwestern University
3112
19
NOK Corporation
2108
19
ProLynx LLC
54
19
Takeda Pharmaceutical Company Limited
2961
17
Ambrx, Inc.
191
17
Other owners 2645